367 Effects of alisertib (MLN8237), an investigational Aurora A kinase inhibitor (AAKi), on the QTc interval in patients (pts) with advanced malignancies. (September 2015) - Zhou, X.; Nemunaitis, J.; Pant, S.; Bauer, T.M.; Patel, M.; Sarantopoulos, J.; Lockhart, A.C.; Goodman, D.; Zhang, B.; Ullmann, C. Dansky; Mould, D.R.; Venkatakrishnan, K.